LT4477B - Fluoksetino enterinės piliulės - Google Patents

Fluoksetino enterinės piliulės Download PDF

Info

Publication number
LT4477B
LT4477B LT98-058A LT98058A LT4477B LT 4477 B LT4477 B LT 4477B LT 98058 A LT98058 A LT 98058A LT 4477 B LT4477 B LT 4477B
Authority
LT
Lithuania
Prior art keywords
fluoxetine
layer
enteric
core
hpmcas
Prior art date
Application number
LT98-058A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT98058A (en
Inventor
Neil Robert Anderson
Roger Garrick Harrison
Daniel Frederick Lynch
Peter Lloyd Oren
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25349313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT4477(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of LT98058A publication Critical patent/LT98058A/xx
Publication of LT4477B publication Critical patent/LT4477B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
LT98-058A 1997-05-29 1998-04-22 Fluoksetino enterinės piliulės LT4477B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/867,196 US5910319A (en) 1997-05-29 1997-05-29 Fluoxetine enteric pellets and methods for their preparation and use

Publications (2)

Publication Number Publication Date
LT98058A LT98058A (en) 1998-10-26
LT4477B true LT4477B (lt) 1999-03-25

Family

ID=25349313

Family Applications (1)

Application Number Title Priority Date Filing Date
LT98-058A LT4477B (lt) 1997-05-29 1998-04-22 Fluoksetino enterinės piliulės

Country Status (46)

Country Link
US (3) US5910319A (sv)
JP (1) JP3210288B2 (sv)
KR (1) KR100549473B1 (sv)
CN (2) CN1161109C (sv)
AR (1) AR011728A1 (sv)
AT (1) AT408068B (sv)
AU (1) AU726690B2 (sv)
BE (1) BE1011925A3 (sv)
BR (1) BR9801989A (sv)
CA (1) CA2234826C (sv)
CH (1) CH693018A5 (sv)
CO (1) CO4940407A1 (sv)
CZ (1) CZ290582B6 (sv)
DE (1) DE19823940B4 (sv)
DK (1) DK176776B1 (sv)
ES (1) ES2161574B1 (sv)
FI (1) FI119971B (sv)
FR (1) FR2763846B1 (sv)
GB (1) GB2325623B (sv)
GR (1) GR980100188A (sv)
HK (1) HK1034902A1 (sv)
HU (1) HUP9800882A3 (sv)
ID (1) ID20343A (sv)
IL (1) IL124073A (sv)
IT (1) ITMI980908A1 (sv)
LT (1) LT4477B (sv)
LU (1) LU90245B1 (sv)
LV (1) LV12176B (sv)
MY (1) MY118139A (sv)
NL (1) NL1009259C2 (sv)
NO (1) NO317743B1 (sv)
NZ (1) NZ330192A (sv)
PE (1) PE75399A1 (sv)
PL (1) PL192293B1 (sv)
PT (1) PT102152B (sv)
RO (1) RO120043B1 (sv)
RS (1) RS49827B (sv)
RU (1) RU2164405C2 (sv)
SE (1) SE522914C2 (sv)
SG (1) SG72805A1 (sv)
SI (1) SI9800128B (sv)
SV (1) SV1998000052A (sv)
TR (1) TR199800937A2 (sv)
TW (1) TWI239838B (sv)
UA (1) UA48193C2 (sv)
ZA (1) ZA983173B (sv)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
CA2698347A1 (en) * 1999-05-20 2000-11-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
EP1225881B1 (en) * 1999-09-03 2006-02-22 APBI Holdings, LLC The use of dapoxetine, a rapid-onset selective serotonin reuptake inhibitor, for treating sexual dysfunction
CN1094347C (zh) * 1999-11-15 2002-11-20 广东药学院药物研究所 一种治疗前列腺良性增生症的控释微丸及其制备方法
US6273260B1 (en) 2000-03-08 2001-08-14 Eli Lilly And Company Pharmaceutical packaging system
ES2185452B2 (es) * 2000-08-01 2004-03-16 Cinfa S A Lab Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
JP4181738B2 (ja) * 2000-08-25 2008-11-19 信越化学工業株式会社 腸溶性コーティング製剤の製造方法
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
WO2002038126A2 (en) * 2000-11-08 2002-05-16 Aeromatic-Fielder Ag A process for production of particles for pharmaceutical compositions having increased bioavailability
WO2003013480A1 (en) 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
US20040170688A1 (en) * 2001-08-06 2004-09-02 Deshmukh Abhijit Mukund Enteric formulation of fluoxetin
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
AU2002361495A1 (en) * 2002-12-24 2004-07-22 Lupin Limited Enteric coated fluoxetine composition
US8614247B2 (en) * 2003-04-10 2013-12-24 Institut National De La Sante Et De La Recherche Medicale Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof
UA82698C2 (uk) 2003-05-30 2008-05-12 Ранбакси Лабораториз Лимитед Заміщені похідні піролу та їх використання в якості інгібіторів hmg-co
US20050176693A1 (en) * 2003-08-12 2005-08-11 Boissonneault Roger M. Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle
CA2552440A1 (en) * 2003-12-30 2005-07-21 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition
ZA200701576B (en) * 2004-04-30 2008-09-25 Astellas Pharma Inc Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
KR100920856B1 (ko) * 2004-11-30 2009-10-09 (주)아모레퍼시픽 선택적 세로토닌 재흡수 억제제의 연장방출 제제 및 그제조방법
EP1730132A2 (en) * 2004-12-23 2006-12-13 Teva Pharmaceutical Industries Ltd Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
WO2007015270A2 (en) * 2005-08-02 2007-02-08 Lupin Limited Novel controlled release compositions of selective serotonin reuptake inhibitors
US8026377B2 (en) 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
AU2006318476A1 (en) * 2005-11-23 2007-05-31 Auspex Pharmaceuticals, Inc. Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
WO2007067581A1 (en) * 2005-12-05 2007-06-14 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride
JP2009527577A (ja) * 2006-02-24 2009-07-30 テバ ファーマシューティカル インダストリーズ リミティド フルバスタチンナトリウム医薬組成物
CN101057837B (zh) * 2006-04-20 2010-12-22 湖南九典制药有限公司 一种右旋酮洛芬肠溶微丸及制备方法
WO2007134168A2 (en) * 2006-05-10 2007-11-22 Dr. Reddy's Laboratories Ltd. Process for preparing duloxetine
KR20090005237A (ko) * 2006-05-22 2009-01-12 테바 파마슈티컬 인더스트리즈 리미티드 둘록세틴 염산염 지연 방출형 제제
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
WO2008014175A2 (en) * 2006-07-28 2008-01-31 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US20090175935A1 (en) * 2006-08-14 2009-07-09 Torrent Research Ltd. Pharmaceutical compositions of duloxetine
AU2007299726A1 (en) * 2006-09-22 2008-03-27 Braincells, Inc. Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
US20080226711A1 (en) * 2007-03-12 2008-09-18 Torrent Pharmaceuticals Ltd. Pharmaceutical compositions of duloxetine
US20090226517A1 (en) * 2008-02-06 2009-09-10 Vinita Umashankar Vyas Pharmaceutical formulations comprising duloxetine
JP5774988B2 (ja) 2008-07-16 2015-09-09 リヒター ゲデオン ニルバーノシャン ミーケデーレスベニュタールシャシャーグ ドーパミン受容体リガンドからなる製剤処方
WO2010026993A1 (ja) * 2008-09-03 2010-03-11 武田薬品工業株式会社 製剤における吸収性改善方法および吸収性が改善された製剤
CN101804145B (zh) * 2009-02-12 2012-11-14 杭州赛利药物研究所有限公司 一种大蒜油肠溶微丸胶囊及其制备方法
WO2011039768A2 (en) * 2009-09-17 2011-04-07 Cadila Healthcare Limited Pharmaceutical compositions for reducing alcohol-induced dose dumping
EP2540318B1 (en) * 2010-02-22 2018-10-24 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
EP3524271A1 (en) * 2012-05-02 2019-08-14 Capsugel Belgium NV Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
CN102716084B (zh) * 2012-06-29 2013-09-25 海南美大制药有限公司 盐酸氟西汀脂质体固体制剂
TWI566786B (zh) 2012-09-03 2017-01-21 第一三共股份有限公司 含有氫化嗎啡酮鹽酸鹽之經口用徐放性醫藥組成物
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP3145498B1 (en) 2014-05-20 2020-03-04 Dow Global Technologies LLC Dispersion comprising a partially neutralized esterified cellulose ether
US9782356B2 (en) 2014-05-20 2017-10-10 Dow Global Technologies Llc Capsule shells comprising an esterified cellulose ether
WO2015187874A1 (en) * 2014-06-07 2015-12-10 Structure-Ase, Inc. A method for the detection and/or diagnosis of eating disorders and malnutrition using x-ray diffraction
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
AU2018250628A1 (en) 2017-04-13 2019-12-05 Chase Therapeutics Corporation Pharmaceutical combination and its use for treating synucleinopathies
HUP1700253A1 (hu) 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
CN107898942B (zh) * 2017-11-24 2021-01-26 一力制药(罗定)有限公司 一种感冒清热胶囊及其制备方法
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
WO2022115054A1 (en) * 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Enteric coated duloxetine compositions

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4444778A (en) 1981-08-27 1984-04-24 Coughlin Shaun R Method and composition for treating atherosclerosis
US4626549A (en) 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4847092A (en) 1985-11-12 1989-07-11 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US5104899A (en) 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
WO1992013452A1 (en) 1991-02-04 1992-08-20 Young James W Methods of use and compositions of r(-) fluoxetine
US5356934A (en) 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
EP0693281A2 (en) 1994-07-20 1996-01-24 Lilly S.A. Fluoxetine Pharmaceutical formulations
US5508276A (en) 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194009A (en) 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
JPS517116A (en) 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
CH649216A5 (de) 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
JPS5855125B2 (ja) * 1980-03-10 1983-12-08 信越化学工業株式会社 固形薬剤用腸溶性コ−テイング剤組成物
US4797286A (en) 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US4918242A (en) 1988-03-30 1990-04-17 Aldrich Chemical Company, Inc. Novel optically 1,3-phenoxypropylhalides
CA1337955C (en) * 1988-09-26 1996-01-23 Thomas A. Almquist Recoating of stereolithographic layers
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
JPH04202124A (ja) * 1990-11-29 1992-07-22 Fuji Kagaku Kogyo Kk 噴霧乾燥造粒法による薬物放出の制御された製剤の製造法
AU657973B2 (en) * 1991-05-07 1995-03-30 Dynagen, Inc. A controlled, sustained release delivery system for smoking cessation
CA2132012C (en) * 1992-03-25 2003-04-22 John W. Shell Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
JPH06293633A (ja) * 1993-04-05 1994-10-21 Shin Etsu Chem Co Ltd 水性腸溶性エマルジョンの製造方法
US5362886A (en) 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
WO1995012385A1 (en) * 1993-11-03 1995-05-11 Isotech Medical, Inc. Microparticular pharmaceutical compositions in micellar form
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
JPH08109126A (ja) * 1994-10-07 1996-04-30 Amano Pharmaceut Co Ltd 耐衝撃性腸溶性顆粒剤およびこれを含有する錠剤
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4626549A (en) 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4444778A (en) 1981-08-27 1984-04-24 Coughlin Shaun R Method and composition for treating atherosclerosis
US4847092A (en) 1985-11-12 1989-07-11 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US5356934A (en) 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5104899A (en) 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
WO1992013452A1 (en) 1991-02-04 1992-08-20 Young James W Methods of use and compositions of r(-) fluoxetine
US5508276A (en) 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
EP0693281A2 (en) 1994-07-20 1996-01-24 Lilly S.A. Fluoxetine Pharmaceutical formulations

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BENAZZI F, MAZZOLI M.: "Fluoxetine-induced sexual dysfunction: a dose-dependent effect?", PHARMACOPSYCHIATRY, 1994, pages 246
BURKE ET AL.: "Weekly Fluoxetine Controls Symptoms of Depression", PSYCHOPHARMACOLOGY BULLETIN, 1995, pages 524
MONTGOMERY D B ET AL.: "Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts", EUR ARCH PSYCHIATRY CLIN NEUROSCI, 1994, pages 211
ROBERTSON DW ET AL.: "Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor", J MED CHEM., 1988, pages 1412, XP000568845, DOI: doi:10.1021/jm00402a027

Also Published As

Publication number Publication date
NL1009259C2 (nl) 1998-12-01
RO120043B1 (ro) 2005-08-30
FR2763846B1 (fr) 2001-05-18
CH693018A5 (de) 2003-01-31
CZ114398A3 (cs) 1998-12-16
GB2325623B (en) 1999-04-14
FI980846A0 (fi) 1998-04-16
YU16598A (en) 1999-11-22
LU90245B1 (fr) 2002-07-31
CZ290582B6 (cs) 2002-08-14
SV1998000052A (es) 1999-03-16
LT98058A (en) 1998-10-26
KR100549473B1 (ko) 2006-03-23
PE75399A1 (es) 1999-08-17
FI980846A (sv) 1998-11-30
PT102152B (pt) 2000-09-29
DE19823940B4 (de) 2010-04-29
CN1200924A (zh) 1998-12-09
CN1161109C (zh) 2004-08-11
ITMI980908A1 (it) 1999-10-28
NZ330192A (en) 1999-08-30
KR19980086622A (ko) 1998-12-05
ID20343A (id) 1998-12-03
ATA93198A (de) 2001-01-15
US5910319A (en) 1999-06-08
DE19823940A1 (de) 1998-12-03
IL124073A (en) 2002-02-10
PT102152A (pt) 1998-12-31
HUP9800882A2 (hu) 2000-03-28
GB9807939D0 (en) 1998-06-10
AT408068B (de) 2001-08-27
LV12176A (lv) 1998-12-20
GR980100188A (el) 1999-01-29
PL326134A1 (en) 1998-12-07
US5985322A (en) 1999-11-16
SE9801336D0 (sv) 1998-04-17
MY118139A (en) 2004-09-30
UA48193C2 (uk) 2002-08-15
GB2325623A (en) 1998-12-02
TR199800937A3 (tr) 1999-10-21
BR9801989A (pt) 2000-02-08
ES2161574B1 (es) 2002-06-16
SE9801336L (sv) 1998-11-30
SE522914C2 (sv) 2004-03-16
HU9800882D0 (en) 1998-05-28
AU726690B2 (en) 2000-11-16
JPH10330253A (ja) 1998-12-15
CO4940407A1 (es) 2000-07-24
IE980284A1 (en) 2000-07-12
FR2763846A1 (fr) 1998-12-04
DK176776B1 (da) 2009-08-10
ZA983173B (en) 1999-10-15
USRE39030E1 (en) 2006-03-21
RU2164405C2 (ru) 2001-03-27
CA2234826A1 (en) 1998-11-29
NO982197D0 (no) 1998-05-14
AR011728A1 (es) 2000-08-30
SG72805A1 (en) 2000-05-23
AU6904898A (en) 1998-12-03
HK1034902A1 (en) 2001-11-09
TR199800937A2 (xx) 1999-10-21
JP3210288B2 (ja) 2001-09-17
NO317743B1 (no) 2004-12-13
BE1011925A3 (fr) 2000-03-07
CA2234826C (en) 2000-12-19
LV12176B (en) 1999-03-20
NO982197L (no) 1998-11-30
CN1212834C (zh) 2005-08-03
HUP9800882A3 (en) 2000-07-28
TWI239838B (en) 2005-09-21
LU90245A1 (sv) 1998-11-30
FI119971B (sv) 2009-05-29
RS49827B (sr) 2008-08-07
SI9800128B (sl) 2000-04-30
CN1285189A (zh) 2001-02-28
PL192293B1 (pl) 2006-09-29
SI9800128A (sl) 1999-02-28
ES2161574A1 (es) 2001-12-01

Similar Documents

Publication Publication Date Title
LT4477B (lt) Fluoksetino enterinės piliulės
RU2147231C1 (ru) Кишечные гранулы дульоксетина
AU771064B2 (en) Opioid analgesics With Controlled Active Substance Release
US6254891B1 (en) Extended release acetaminophen
SK50442006A3 (sk) Pelety obsahujúce hydrochlorid venlafaxínu
CN101330913A (zh) 依他普仑的修饰和脉冲释放药物制剂
MXPA98003636A (es) Granulos entericos de fluoxetina
IE83510B1 (en) Fluoxetine enteric pellets

Legal Events

Date Code Title Description
MK9A Expiry of a patent

Effective date: 20180422